Showing results (121-130 of 439) with videos related to

Sort By:
Pageof 44
British Journal of Haematology|July 26, 2002
Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: what is the EVI-1 gene role?Massimo Breccia, Maria C Petti, Emanuela Ottaviani, et al.
Health and Quality of Life Outcomes|October 20, 2017
Physicians' attitude towards selection of second line therapy with nilotinib and dasatinib in chronic myeloid leukemia patientsMassimo Breccia, Michele Baccarani, Gianantonio Rosti, et al.
Leukemia & Lymphoma|March 23, 2010
Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patientsMassimo Breccia, Roberto Latagliata, Laura Cannella, et al.
Pathologica|June 6, 2025
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusion: report of two cases with different clinical presentationElisabetta Merenda, Katia Paciaroni, Emilia Scalzulli, et al.
Leukemia Research|December 25, 2012
Influence of time to complete remission and duration of all-trans retinoic acid therapy on the relapse risk in patients with acute promyelocytic leukemia receiving AIDA protocolsMassimo Breccia, Clara Minotti, Roberto Latagliata, et al.
Frontiers in Oncology|August 8, 2024
Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectivesMassimo Breccia, Francesca Palandri, Nicola Polverelli, et al.
Haematologica|May 12, 2004
Arsenic trioxide in the treatment of advanced acute promyelocytic leukemiaIda Carmosino, Roberto Latagliata, Giuseppe Avvisati, et al.
Leukemia Research|June 2, 2005
Myelodysplastic syndromes in patients under 50 years old: a single institution experienceMassimo Breccia, Andrea Mengarelli, Marco Mancini, et al.
Expert Review of Hematology|September 3, 2020
The advantages and risks of ruxolitinib for the treatment of polycythemia veraGioia Colafigli, Emilia Scalzulli, Sara Pepe, et al.
Leukemia & Lymphoma|December 5, 2008
Differences in hematological and non-hematological toxicity during treatment with imatinib in patients with early and late chronic phase chronic myeloid leukemiaMassimo Breccia, Caterina Stefanizzi, Laura Cannella, et al.
Pageof 44